Nagae S, Ushijima M, Hatono S, Imai J, Kasuga S, Matsuura H, Itakura Y, Higashi Y
Institute for OTC Research, Wakunaga Pharmaceutical Co., Ltd., Hiroshima, Japan.
Planta Med. 1994 Jun;60(3):214-7. doi: 10.1055/s-2006-959461.
The pharmacokinetic behavior of S-allylcysteine (SAC), one of the biologically active transformation products from garlic, was investigated after oral administration to rats, mice, and dogs. SAC was rapidly and easily absorbed in the gastrointestinal tract and distributed mainly in plasma, liver, and kidney. The bioavailability was 98.2, 103.0, and 87.2% in rats, mice, and dogs, respectively. SAC was mainly excreted into urine in the N-acetyl form in rats; however, mice excreted both SAC and the N-acetyl form. The half-life of SAC was longer in dogs than in rats and mice.
大蒜的生物活性转化产物之一S-烯丙基半胱氨酸(SAC)经口服给予大鼠、小鼠和犬后,对其药代动力学行为进行了研究。SAC在胃肠道中迅速且易于吸收,主要分布于血浆、肝脏和肾脏。在大鼠、小鼠和犬中的生物利用度分别为98.2%、103.0%和87.2%。在大鼠中,SAC主要以N-乙酰化形式排泄到尿液中;然而,小鼠排泄的既有SAC也有N-乙酰化形式。SAC在犬中的半衰期比在大鼠和小鼠中更长。